Biomarkers in Blood and Tissue Samples From Patients With Uterine Cancer
Completed
360 enrolled
Sunitinib in Treating Patients With Newly Diagnosed Stage II or Stage III Breast Cancer That Can Be Removed by Surgery
Phase 2 Completed
4 enrolled
AEG35156 and Docetaxel in Treating Patients With Locally Advanced, Metastatic, or Recurrent Solid Tumors
Phase 1 Completed
27 enrolled
Temozolomide + Everolimus in Newly Diagnosed, Recurrent, or Progressive Malignant Glioblastoma Multiforme
Phase 1 Completed
32 enrolled
SB939 in Treating Patients With Locally Advanced or Metastatic Solid Tumors
Phase 1 Completed
39 enrolled
Interleukin-21 in Treating Patients With Metastatic or Recurrent Malignant Melanoma
Phase 2 Completed
40 enrolled
Ridaforolimus in Treating Patients With Recurrent Metastatic and/or Locally Advanced Endometrial Cancer
Phase 2 Completed
35 enrolled
Biomarkers in Patients With Stage III or Stage IV Follicular Lymphoma Treated on Clinical Trial E-1496
Completed
175 enrolled
S9704-S0014-S0313A Studying Genes in Samples From Patients With Limited or Advanced Diffuse Large B-Cell Lymphoma
Completed
397 enrolled
Combination Chemotherapy and Radiation Therapy With or Without Lapatinib in Treating Patients With Locally Advanced Cancer of the Larynx or Hypopharynx
Phase 1/2 Completed
7 enrolled
Combination Chemotherapy and Rituximab in Treating Patients With Newly Diagnosed AIDS-Related B-Cell Non-Hodgkin's Lymphoma
Phase 2 Completed
43 enrolled 7 charts
Gene Expression in Patients With Advanced or Metastatic Colorectal Cancer Receiving Bevacizumab
Completed
200 enrolled
Study of Tissue and Blood Samples From Patients With Recurrent Prostate Cancer Who Received Lapatinib on Clinical Trial ECOG-E5803
Completed
37 enrolled
Studying Tumor Samples From Women Who Have Undergone Chemotherapy for Breast Cancer
Completed
2,541 enrolled
Study of Tumor Tissue From Patients With Melanoma Treated on Clinical Trial EST-1690
Completed
307 enrolled
Biomarkers in Samples From Patients With Follicular Lymphoma Treated With Rituximab
Completed
559 enrolled
Biomarkers in Tissue Samples From Patients With Breast Cancer Treated With Bevacizumab
Completed
363 enrolled
Biomakers in Tissue Samples From Patients With Recurrent and/or Metastatic Squamous Cell Cancer of the Head and Neck Previously Treated With Cisplatin With or Without Cetuximab
Completed
79 enrolled
Biomarkers of Response in Blood and Tumor Tissue Samples From Patients With Unresectable Stage IV Squamous Cell Cancer of the Head and Neck Previously Treated With Cetuximab, Cisplatin, and Radiation Therapy
Completed
69 enrolled
Biomarkers in Patients With Metastatic or Recurrent Head and Neck Cancer Treated With Cisplatin and Cetuximab on ECOG-E5397
Completed
42 enrolled
Biomarkers in Tissue Samples From Patients With Recurrent or Metastatic Head and Neck Cancer Treated on ECOG-E1395 and ECOG-E3301
Completed
155 enrolled
S8809-S9800-S9911TM- Biological Markers in Patients With Follicular Lymphoma Treated on Clinical Trial SWOG-8809, SWOG-9800, or SWOG-9911
Completed
180 enrolled
Studying Gene Expression in Samples From Patients With Rhabdoid Tumors
Completed
25 enrolled
Biomarker in Tissue Samples From Patients With Ewing Sarcoma
Completed
40 enrolled
Biomarkers in Tumor Samples From Younger Patients With Neuroblastoma
Completed
5 enrolled
Biomarker in Tumor Tissue Samples From Patients With Rhabdomyosarcoma
Completed
60 enrolled
Biomarker Expression in Samples From Young Patients With Anaplastic Large Cell Lymphoma
Completed
7 enrolled
Biomarkers in Blood and Tissue Samples From Patients With Newly Diagnosed Neuroblastoma
Completed
300 enrolled
Protein Expression in Samples From Young Patients With Rhabdomyosarcoma
Completed
77 enrolled
Studying Biomarkers in Samples From Younger Patients With Wilms Tumor
Completed
20 enrolled
Studying Gene Expression and Location in Samples From Patients With Brain Tumors
Completed
10 enrolled
Protein Biomarker Levels in Tissue Samples From Young Patients With Low-risk Hodgkin Lymphoma
Completed
23 enrolled
Biomarkers in Samples From Young Patients With Neuroblastoma
Completed
20 enrolled
Lapatinib and Epirubicin in Treating Patients With Metastatic Breast Cancer. ICORG 06-30
Phase 1 Completed
10 enrolled
S0424 - Carcinogens in Lung Tissue From Smokers (Closed to Entry as of 7/15/07) and Non-Smokers With Newly Diagnosed Stage I, Stage II, or Stage III Non-Small Cell Lung Cancer
Completed
981 enrolled
S9313B Study of Tumor Tissue Samples From Women With Early-Stage Breast Cancer Enrolled on Clinical Trial SWOG-9313
Completed
1,600 enrolled
Biomarker (p53 Gene) Analysis and Combination Chemotherapy Followed by Radiation Therapy and Surgery in Treating Women With Large Operable or Locally Advanced or Inflammatory Breast Cancer
Phase 3 Completed
1,856 enrolled
Studying Tumor Tissue Samples to Learn More About DNA Changes and Response in Patients With Breast Cancer Treated With Bevacizumab on Clinical Trial ECOG-2100
Completed
500 enrolled
Epothilone ZK-219477 in Treating Patients With Recurrent Glioblastoma
Phase 2 Completed
38 enrolled